Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D05SXU
|
|||
Former ID |
DNC006007
|
|||
Drug Name |
2-(2-naphthamido)benzoic acid
|
|||
Synonyms |
2-(2-naphthamido)benzoic acid; SCHEMBL8044197; CHEMBL200536; BDBM16098; 2-(naphthalene-2-amido)benzoic acid; AKOS000132452; 2-[(naphthalen-2-ylcarbonyl)amino]benzoic acid
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C18H13NO3
|
|||
Canonical SMILES |
C1=CC=C2C=C(C=CC2=C1)C(=O)NC3=CC=CC=C3C(=O)O
|
|||
InChI |
1S/C18H13NO3/c20-17(19-16-8-4-3-7-15(16)18(21)22)14-10-9-12-5-1-2-6-13(12)11-14/h1-11H,(H,19,20)(H,21,22)
|
|||
InChIKey |
BBJZKXXWFJLNRR-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Plasmodium Dihydroorotate dehydrogenase (Malaria DHOdehase) | Target Info | Inhibitor | [1] |
KEGG Pathway | Pyrimidine metabolism | |||
Metabolic pathways | ||||
Pathwhiz Pathway | Pyrimidine Metabolism | |||
Reactome | Pyrimidine biosynthesis | |||
WikiPathways | Metabolism of nucleotides |
References | Top | |||
---|---|---|---|---|
REF 1 | The first de novo designed inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase. Bioorg Med Chem Lett. 2006 Jan 1;16(1):88-92. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.